 | C4 Therapeutics, Inc. | |||
| NMS : CCCC || Location: United States | ||||
$6.28+0.04 (+0.64%) |
0.35 M | 6.19 - 6.37 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 9.563 M |
| March 28, 2024 | 9.149 M |
| March 15, 2024 | 5.287 M |
| Feb. 29, 2024 | 2.967 M |
| Feb. 15, 2024 | 3.177 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.70 | -0.70 | -0.55% |
| 09/30/2023 | -0.67 | -0.52 | 22.76% |
| 06/30/2023 | -0.70 | -0.73 | -4.06% |
| 03/31/2023 | -0.76 | -0.71 | 6.65% |
| 12/31/2022 | -0.76 | -0.77 | -1.50% |
CCCC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 68.601M | Shares Float | 52.504M |
| Short Float | 9.563M | Market Cap | 428.07M |
| Institution ownership | 76.51% | Insider ownership | 11.619% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.67 | Forward EPS | -1.92 |